Shares of Gilead Sciences Inc. rose 3.07% to $106.34 Monday, on what proved to be an all-around great trading session for the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

Gilead Sciences (NASDAQ: GILD) didn't have a bad first quarter, but investors didn't find it inspiring either. After ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

As the Trump administration stares down diversity programs, this big Peninsula employer is highlighting its efforts.

As the final season of The Handmaid's Tale approaches, fans are on tenterhooks to find out if June Osborne (portrayed by ...

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways in which the ...

It seems unlikely that The Handmaid’s Tale is going to end with June Osborne ( Elisabeth Moss) and Nick Blaine (Max Minghella ...

Nick and June are reunited in The Handmaid’s Tale Season 6 Episode 6, ‘Surprise’, but does it end well? Here’s your full recap.

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

The Handmaid's Tale' is inching towards its conclusion and June, Luke and Moira are putting their plans to take down Gilead ...